Loading stock data...

Natural Capsules Limited

BSE: NATCAPSUQ

BSE
272.00 -1.10 (-0.40%)

Prev Close

273.1

Open Price

280.45

Volume

400

Today Low / High

272 / 280.75

52 WK Low / High

163.55 / 299

Range

258 - 286

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 272, reflecting a change of -1.1 (-0.40278%). The expected target range on the BSE is 258 - 286. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

01 Oct 280.45 -3.01%
30 Sep 275.00 -0.69%
29 Sep 272.20 1.56%
26 Sep 271.95 0.09%
25 Sep 221.20 17.31%
24 Sep 224.45 -3.65%
23 Sep 234.45 -3.90%
22 Sep 278.05 -16.56%
19 Sep 210.95 16.64%
18 Sep 190.00 7.92%
17 Sep 188.45 -0.16%
16 Sep 192.00 -2.40%
15 Sep 193.00 -1.14%
12 Sep 189.35 2.96%
11 Sep 199.00 -5.23%
10 Sep 202.55 -3.26%
09 Sep 206.90 -1.98%
08 Sep 207.25 1.21%
05 Sep 215.00 -3.26%
04 Sep 209.30 1.10%

Natural Capsules Limited Graph

Natural Capsules Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Natural Capsules Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 272.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 272.00 274.72 247.25 - 302.19
277.44 221.95 - 332.93
280.16 196.11 - 364.21
Bearish Scenario 272.00 269.28 242.35 - 296.21
266.56 213.25 - 319.87
263.84 184.69 - 342.99

Overview of Natural Capsules Limited

ISIN

INE936B01015

Industry

Medical - Pharmaceuticals

Vol.Avg

5,811

Market Cap

2,812,793,888

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of NATCAPSUQ

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2023-07-20 July 20, 23 1 1 2023-07-20 2023-08-27
2022-09-09 September 09, 22 1 1 2022-09-12 2022-10-20
2021-07-06 July 06, 21 0.81999 0.81999 2021-07-07 2021-08-14
2020-08-12 August 12, 20 0.492 0.492 2020-08-13 2020-09-20
2019-08-13 August 13, 19 0.81999 0.81999 2019-08-14 2019-09-21

Stock Rating Details for NATCAPSUQ

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 169.21 Cr 108.15 Cr 61.05 Cr 0.3608 0.00 Cr 14.13 Cr 8.40 Cr 0.62 Cr 0.58 18.22 Cr 0.0036
2024-03-31 155.42 Cr 99.71 Cr 55.71 Cr 0.3584 2.08 Cr 2.05 Cr 11.24 Cr 5.55 Cr 5.97 21.99 Cr 0.0357
2023-03-31 172.37 Cr 78.68 Cr 93.69 Cr 0.5435 2.39 Cr 1.66 Cr 27.24 Cr 18.45 Cr 19.89 35.93 Cr 0.1070
2022-03-31 135.07 Cr 59.80 Cr 75.26 Cr 0.5572 2.12 Cr 1.85 Cr 20.28 Cr 13.91 Cr 19.84 26.51 Cr 0.1030
2021-03-31 79.51 Cr 37.43 Cr 42.09 Cr 0.5293 0.98 Cr 1.06 Cr 31.60 Cr 6.91 Cr 11.09 14.01 Cr 0.0869

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.75 Cr 419.35 Cr 162.19 Cr 232.9361 Cr 105.19 Cr 99.91 Cr 25.46 Cr 283.63 Cr 0.00 Cr 0.00 Cr 3.51 Cr 99.9928 Cr
2024-03-31 1.95 Cr 376.53 Cr 147.72 Cr 203.8001 Cr 109.01 Cr 107.06 Cr 19.04 Cr 246.10 Cr 0.00 Cr 0.00 Cr 2.73 Cr 76.4739 Cr
2023-03-31 1.27 Cr 288.76 Cr 140.52 Cr 123.2261 Cr 96.79 Cr 95.52 Cr 8.85 Cr 183.36 Cr 12.53 Cr 0.15 Cr 0.60 Cr 66.9419 Cr
2022-03-31 1.40 Cr 164.28 Cr 81.30 Cr 82.9793 Cr 52.78 Cr 51.38 Cr 4.58 Cr 84.85 Cr 10.31 Cr 0.00 Cr 0.52 Cr 44.7680 Cr
2021-03-31 0.10 Cr 97.04 Cr 34.94 Cr 62.0954 Cr 10.29 Cr 10.19 Cr 6.61 Cr 45.08 Cr 6.01 Cr 0.12 Cr 0.79 Cr 33.3921 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 14.0945 Cr -44.6302 Cr 22.4799 Cr -30.5357 Cr 2.9505 Cr 5.2842 Cr -44.6302 Cr 0.6174 Cr -5.1888 Cr 0.0000 Cr -6.4215 Cr
2024-03-31 -8.3538 Cr -72.5861 Cr 81.7169 Cr -79.9822 Cr 0.7771 Cr 2.2548 Cr -71.6284 Cr 5.5535 Cr 12.4613 Cr -0.9298 Cr -10.1868 Cr
2023-03-31 17.2167 Cr -104.6295 Cr 87.4920 Cr -88.6743 Cr 0.0792 Cr 1.4777 Cr -105.8910 Cr 24.9927 Cr 44.2684 Cr -0.7720 Cr -4.2708 Cr
2022-03-31 -0.5218 Cr -45.8750 Cr 47.6977 Cr -46.6021 Cr 1.3009 Cr 1.3985 Cr -46.0803 Cr 19.3865 Cr 42.6356 Cr -0.6233 Cr 2.0316 Cr
2021-03-31 5.7885 Cr -8.5385 Cr 2.5194 Cr -10.6330 Cr -0.2306 Cr 0.0976 Cr -16.4215 Cr 9.1902 Cr 3.3667 Cr -0.3740 Cr -1.3291 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 45.20 Cr 23.57 Cr 21.63 Cr 0.4785 -3.89 Cr -5.58 Cr -5.40 0.68 Cr -0.1235
2025-03-31 44.97 Cr 28.67 Cr 16.30 Cr 0.3624 2.23 Cr 0.52 Cr 0.49 4.69 Cr 0.0116
2024-12-31 43.83 Cr 22.29 Cr 21.54 Cr 0.4915 1.93 Cr 0.11 Cr 0.10 4.38 Cr 0.0024
2024-09-30 41.22 Cr 19.83 Cr 21.40 Cr 0.5190 2.16 Cr -0.61 Cr -0.60 4.61 Cr -0.0149
2024-06-30 39.18 Cr 25.57 Cr 13.61 Cr 0.3474 2.08 Cr 0.60 Cr 0.64 4.54 Cr 0.0153

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 5.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -257.16 Cr
2025-03-31 5.28 Cr 4.54 Cr 5.28 Cr 62.24 Cr 25.46 Cr 129.59 Cr 283.63 Cr 419.35 Cr 162.19 Cr
2024-12-31 0.00 Cr 0.00 Cr 14.06 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -258.33 Cr
2024-09-30 9.45 Cr 4.61 Cr 14.06 Cr 63.10 Cr 22.09 Cr 134.94 Cr 263.55 Cr 404.66 Cr 146.32 Cr
2024-06-30 0.00 Cr 0.00 Cr 13.26 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -228.80 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -5.58 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.52 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2021-11-11 November 11, 21 1219:1000

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹741.10 ₹88,742,053,847.00 ₹95,115.00

Key Executives

Site Head
Kamlesh Thakur

Gender: Not Specified

Year Born:

Whole Time Director
Mr. Laxminarayana Mundra

Gender: male

Year Born: 1941

Senior Manager of Administration
Mr. V. Lokesh

Gender: male

Year Born:

General Manager of Marketing
Mr. R. Mallikarjuna Rao

Gender: male

Year Born:

GM & Plant Head of NCL Unit-2
Dipankar Mandal

Gender: Not Specified

Year Born:

Chief Financial Officer
Mr. Raj Kishore Prasad

Gender: male

Year Born:

MD & Executive Director
Mr. Sunil Laxminarayana Kumar Mundra

Gender: male

Year Born: 1964

Whole Time Director
Mr. Satyanarayana Mundra

Gender: male

Year Born: 1951

Chief Operating Officer
Mr. M. V. N. Kutty

Gender: male

Year Born:

FAQs about Natural Capsules Limited

Who is the CEO of the company?

The CEO is Sunil Laxminarayana Kumar Mundra.

What is the current market price of the stock?

The current price is ₹272.00.

What is the 52-week price range?

The range is ₹163.55-299.

What is the market capitalization of the company?

The market capitalization is ₹281.28 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -50.50.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Natural Capsules Limited (ISIN: INE936B01015) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹281.28 crores and an average daily volume of 5,811 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.